Biologics and Clinical Immunology Cohort At Sinai
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Mar 2, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The "Biologics And Clinical Immunology Cohort at Sinai" trial is studying how patients with immunological diseases, autoimmune diseases, and primary immune deficiencies respond to biologic therapies, which are special medications that help manage these conditions. The goal of the study is to create a database that collects important health information from patients treated at the Mount Sinai Therapeutic Infusion Center and related clinics. This information will help researchers better understand how these treatments work and how to improve their effectiveness for patients.
To participate in this study, you need to be at least 12 years old, receive medical care at Mount Sinai, and be currently taking a biologic medication or an immune modulator. If you're eligible and decide to join, you’ll provide health information that can support future research in this area. The study is currently recruiting participants, and it welcomes everyone, regardless of gender. Your involvement would contribute to important insights that could enhance treatment for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 12 years and up.
- • Able to provide informed consent.
- • Medical care at Mount Sinai.
- • Receiving a biologic medication or immune modulator at Mount Sinai, or considered an appropriate negative control or comparison participant by the study team.
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Rachel Miller
Principal Investigator
Icahn School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials